EBS:NYE-Emergent Biosolutions Inc (USD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 5.17

Change

+0.43 (+9.07)%

Market Cap

N/A

Volume

1.93M

Analyst Target

USD 112.29
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-02 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
ZTS Zoetis Inc

+1.59 (+0.98%)

USD 72.21B
TAK Takeda Pharmaceutical Co Ltd A..

+0.08 (+0.54%)

USD 47.88B
HLN Haleon plc

-0.02 (-0.20%)

USD 46.89B
RDY Dr. Reddy’s Laboratories Ltd..

+0.07 (+0.53%)

USD 10.62B
ELAN Elanco Animal Health

+0.42 (+4.06%)

USD 5.51B
AMRX Amneal Pharmaceuticals, Inc. C..

-0.06 (-0.73%)

USD 4.11B
BHC Bausch Health Companies Inc

-0.14 (-2.24%)

USD 2.64B
CPHI China Pharma Holdings Inc

+0.01 (+2.12%)

USD 3.69M
YCBD cbdMD Inc

-0.03 (-9.01%)

USD 1.96M
EVT Eaton Vance Tax Advantaged Div..

+0.12 (+0.52%)

N/A

ETFs Containing EBS

EBNK:CA Evolve European Banks Enh.. 5.08 % 0.00 %

+0.04 (+0.38%)

CAD 8.61M
PIEQ Principal International E.. 3.81 % 0.00 %

+0.10 (+0.38%)

USD 0.72B
EMUM:SW iShares MSCI EMU Mid Cap .. 2.10 % 0.00 %

-0.02 (0.38%)

USD 0.17B
LDEG:LSE L&G Quality Equity Divide.. 1.30 % 0.00 %

-3.60 (0.38%)

N/A
FDT First Trust Developed Mar.. 0.00 % 0.80 %

+0.19 (+0.38%)

USD 0.43B
EUMD:LSE iShares MSCI Europe Mid C.. 0.00 % 0.00 %

-0.05 (0.38%)

USD 0.32B
IS3H:F iShares IV Public Limited.. 0.00 % 0.00 %

N/A

N/A
C005:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

-0.80 (0.38%)

USD 0.13B
EL43:XETRA Deka MSCI Europe MC UCITS.. 0.00 % 0.00 %

-0.12 (0.38%)

USD 0.02B
IS3H:XETRA iShares MSCI EMU Mid Cap .. 0.00 % 0.00 %

-0.37 (0.38%)

N/A
IS3T:XETRA iShares MSCI World Size F.. 0.00 % 0.00 %

-0.14 (0.38%)

N/A
FTEU:LSE First Trust Eurozone Alph.. 0.00 % 0.00 %

+0.07 (+0.38%)

USD 0.05B
FTGE:XETRA First Trust Eurozone Alph.. 0.00 % 0.00 %

-0.13 (0.38%)

N/A
IWSZ:SW iShares Edge MSCI World S.. 0.00 % 0.00 %

N/A

USD 0.28B

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -45.92% 7% C- 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -45.92% 7% C- 2% F
Trailing 12 Months  
Capital Gain 128.76% 100% F 99% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 128.76% 100% F 99% N/A
Trailing 5 Years  
Capital Gain -91.03% 23% F 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -91.03% 23% F 2% F
Average Annual (5 Year Horizon)  
Capital Gain -5.68% 29% F 11% F
Dividend Return -5.68% 29% F 9% A-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 132.43% 21% F 6% D-
Risk Adjusted Return -4.29% 36% F 19% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector